Skip to main content

AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise.  The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).

Learn more about the comment process

AMIA responses are arranged by Federal Agency and Congressional Committee.

Showing 31 - 40 out of 75

AMIA Pushes for Informatics Representation on Potential HHS Workgroup

July 11, 2018

In response to an HHS request for information on the creation of a new Healthcare Sector Innovation and Investment Workgroup, AMIA strongly recommended the inclusion of representatives of the health informatics community. Additionally, AMIA called for HHS to orient the Workgroup towards innovating and investing in areas that are strategically […]

AMIA Provides FDA Lit Review on Risk and Benefits of Medical Software

June 28, 2018

AMIA responded to an FDA request for input with a preliminary review of relevant research into the specific benefits and risks to health associated with software functions that the 21st Century Cures Act excluded from the definition of medical device. While some health IT applications to healthcare delivery have unambiguously […]

AMIA and Pew Letter to ONC on 21st Century Cures EHR Reporting Measures

December 14, 2017

Under the 21st Century Cures Act, the Office of the National Coordinator for Health IT (ONC) is supposed to implement an EHR reporting program. However, recent budget proposals would cut ONC’s funding – something ONC officials have said would prevent them from fully implementing this safety provision. The Cures Act […]

AMIA Calls on Lawmakers to Support Students in Tax Reform

December 12, 2017

In a letter sent to the Senate Finance and House Ways & Means committees, the American Medical Informatics Association (AMIA) urged leadership to abandon potential tax reform provisions that would count graduate student tuition waivers as taxable income.

AMIA Comments on CMS Innovation Center RFI

November 21, 2017

In response to a CMS Innovation Center request for information (RFI) on its potential new direction, AMIA offered several suggestions focusing on the interdependency of payment and delivery reforms, supported by health IT and health informatics. AMIA suggested additional guiding principles with which to approach new Innovation Center model design […]

AMIA Supports VA Telehealth Expansion Proposal

November 2, 2017

AMIA provided comments to a VA proposed rule that would allow its providers to furnish telehealth services, regardless of the state or location where they or the beneficiary is physically located. AMIA supported the proposal, while emphasizing that any telehealth applications use nationally recognized health IT standards and enable use […]

AMIA Supports Federal Health IT Research & Development Framework

July 12, 2017

In comments submitted to the Networking and Information Technology Research and Development (NITRD) Program, the nation’s leading biomedical and health informaticians applauded federal officials for developing a draft strategic framework for health IT research and development (R&D). AMIA provided a series of recommendations highlighting the need for R&D related to […]

AMIA Response to NLM Strategic Plan

January 31, 2017

In comments submitted to the National Library of Medicine, AMIA said members envision a future where NLM leads the medical and research enterprise in demonstrating how real-world and “big” health data can be leveraged to develop new concepts of human disease, design novel therapies, and train future clinicians and researchers.

AMIA Comments Regarding FDA’s Medical Device User Fee Agreement Letter (MDUFA IV)

November 2, 2016

In comments submitted to the FDA, AMIA voiced supported for several aspects of MDUFA IV meant to enhance use of consensus standards; develop patient engagement strategies and improve the science of patient input; utilize real world evidence (RWE) to improve regulatory decision-making; and development of a policy framework for Digital […]